Adam J. Rabalski

Associate Director, Chemical Biology @Odyssey Therapeutics

Boston, MA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Nov 2022 — Present

Associate Director, Chemical Biology @Odyssey Therapeutics

View department →

Boston, MA, US

Mass spectrometry lead for covalent small molecule discovery platform. Coordinated platform discovery efforts with team members to ensure seamless project execution and internalized bottom-up and intact protein MS capabilities to deliver covalent fragment library screening and protein QC capability. Executed TIDVAL activities for targets using covalent profiling and photoaffinity labeling methods. Developed and optimized 96 to 384 well NanoBit and AlphaLISA assays for various targets through HTL. Implemented automation protocols for HTS assay development enabling rapid turnaround of assay results.

EDUCATION

2007 — 2011

University of Guelph

Bachelor's Degree, Biological and Biomedical Sciences

2011 — 2017

Western University

Doctor of Philosophy (Ph.D.), Biochemistry

ABOUT ADAM J. RABALSKI

Chemical biologist with 9 years of industry experience in pharma and biotech, specializing in target-centric and platform drug discovery through biochemical and cellular HTS, advanced proteomics, automation and innovative method creation for challenging biological targets.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Adam J. Rabalski — Associate Director, Chemical Biology at Odyssey Therapeutics in Boston, MA, US | Unifers